Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Link opens in a new tab
English
Español
Search content at University of Kentucky
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Inhibitors of the immunoproteasome: current status and future directions
Zachary Miller
, Lin Ao
, Kyung B.o. Kim
, Wooin Lee
Pharmaceutical Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
84
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Inhibitors of the immunoproteasome: current status and future directions'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine and Dentistry
Proteasome
100%
Diseases
66%
Malignant Neoplasm
33%
Proteasome Inhibitor
33%
Ubiquitin
33%
Hematologic Malignancy
16%
Inflammatory Disorder
16%
Immune Function
16%
Protein Homeostasis
16%
Disease Model
16%
Bortezomib
16%
Antigen Presentation
16%
Adaptive Immunity
16%
Biological Functions
16%
Carfilzomib
16%
Side Effect
16%
Pharmacology, Toxicology and Pharmaceutical Science
Proteasome
100%
Diseases
66%
Malignant Neoplasm
33%
Ubiquitin
33%
Proteasome Inhibitor
33%
Cellular Processes
16%
Inflammatory Disease
16%
Hematologic Malignancy
16%
Bortezomib
16%
Disease Model
16%
Carfilzomib
16%
Side Effect
16%
Biochemistry, Genetics and Molecular Biology
Proteasome
100%
Proteasome Inhibitor
33%
Ubiquitin
33%
Enzymatic Activity
16%
Protein Homeostasis
16%
Biological Functions
16%
Adaptive Immunity
16%
Antigen Presentation
16%
Immunology and Microbiology
Proteasome
100%
Ubiquitins
25%
Inflammatory Disorder
12%
Adaptive Immune System
12%
Biological Functions
12%
Protein Homeostasis
12%
Antigen Presentation
12%